EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sequence diversity of apidaecin-like peptides arresting the terminating ribosome

Weiping Huang, Chetana Baliga iD, Nora Vázquez-Laslop iD, Alexander S Mankin iD

Nucleic Acids Research · 2024

DOI: 10.1093/nar/gkae567 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2024. Verfasst von Weiping Huang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences and Center for Biomolecular Sciences, University of Illinois at Chicago, Chicago, IL 60607, USA. Hauptthemen laut MEDLINE: Ribosomes, Antimicrobial Cationic Peptides. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Proline-rich Antimicrobial Peptide (PrAMP) apidaecin (Api) inhibits translation by binding in the ribosomal nascent peptide exit tunnel, trapping release factors RF1 or RF2, and arresting ribosomes at stop codons. To explore the extent of sequence variations of the native 18-amino acid Api that allows it to preserve its activity, we screened a library of synthetic mutant Api genes expressed in bacterial cells, resulting in nearly 350000 peptide variants with multiple substitutions. By applying orthogonal negative and positive selection strategies, we identified a number of multi-substituted Api variants capable of arresting ribosomes at stop codons. Our findings underscore the critical contribution of specific amino acid residues of the peptide for its on-target function while significantly expanding the variety of PrAMPs acting on the terminating ribosome. Additionally, some of the tested synthesized multi-substituted Api variants exhibit improved antibacterial activity compared to that of the wild type PrAMP and may constitute the starting point to develop clinically useful antimicrobials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RibosomesAntimicrobial Cationic PeptidesCodon, TerminatorEscherichia coliAnti-Bacterial AgentsAmino Acid SequenceProtein BiosynthesisPeptide Chain Termination, TranslationalMutation

Substanzen

apidaecinAntimicrobial Cationic PeptidesCodon, TerminatorAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences and Center for Biomolecular Sciences, University of Illinois at Chicago, Chicago, IL 60607, USA.

ORCID-Profile: Chetana Baliga, Nora Vázquez-Laslop, Alexander S Mankin

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Huang, W., Baliga, C., Vázquez-Laslop, N., & Mankin, A. S. (2024). Sequence diversity of apidaecin-like peptides arresting the terminating ribosome. Nucleic Acids Research. https://doi.org/10.1093/nar/gkae567

Vancouver

Huang W, Baliga C, Vázquez-Laslop N, Mankin AS. Sequence diversity of apidaecin-like peptides arresting the terminating ribosome. Nucleic Acids Research. 2024. doi:10.1093/nar/gkae567

BibTeX
@article{Huang2024,
  author = {Huang, Weiping and Baliga, Chetana and Vázquez-Laslop, Nora and Mankin, Alexander S},
  title = {Sequence diversity of apidaecin-like peptides arresting the terminating ribosome},
  journal = {Nucleic Acids Research},
  year = {2024},
  doi = {10.1093/nar/gkae567}
}
Kostenlos starten →